Catalyst Biosciences Announces Closing of Public Offering of Common Stock
February 15, 2018 at 17:36 PM EST
Catalyst Biosciences, today announced the closing of an underwritten public offering of 3,382,352 shares of its common stock, offered at a price of $34.00 per share to the public.
